Concepedia

Author

Hirotake Tsukamoto

Kumamoto UniversityORCID

Also Known As

H. TSUKAMOTO, H. Tsukamoto, HIROTAKE TSUKAMOTO, Hirotake Tsukamoto, Tsukamoto Hirotake

171

Publications

2.3K

Citations

25

H-Index

42

Concepts

All Affiliations

Kumamoto UniversityKyoto UniversityThe University of TokyoSojo UniversityTrudeau Institute
HT

About

Hirotake Tsukamoto is an author at Kumamoto University specializing in immunology, cell biology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

14

540

2

Cell Biology

11

14

540

3

Immunology

11

14

540

4

Autoimmune Disease

5

5

314

5

Cellular Therapies

1

1

15

Hirotake Tsukamoto

×

34

Publications

1.8K

Citations

24

H-Index

YearCitations

Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment

Hirotake Tsukamoto, Koji Fujieda, Azusa Miyashita,

Cancer Research

2018

292

Age-associated increase in lifespan of naïve CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects

Hirotake Tsukamoto, Karen Clise-Dwyer, Gail E. Huston,

Proceedings of the National Academy of Sciences

2009

174

IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age

Hirotake Tsukamoto, Satoru Senju, Keiko Matsumura,

Nature Communications

2015

97

Wnt Signaling Regulates Hemopoiesis Through Stromal Cells

Toshiyuki Yamane, Takahiro Kunisada, Hirotake Tsukamoto,

The Journal of Immunology

2001

93

Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression

Hirotake Tsukamoto, Ryutaro Nishikata, Satoru Senju,

Cancer Immunology Research

2013

86

Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

Takahiko Akiyama, Tadahito Yasuda, Tomoyuki Uchihara,

Cancer Research

2022

79

Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor

Yusuke Tomita, Akira Yuno, Hirotake Tsukamoto,

Clinical Cancer Research

2013

71

Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis

Yoshihiro Yoshitake, Tetsuya Nakatsura, Mikio Monji,

Clinical Cancer Research

2004

66

Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events

Hirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita,

Proceedings of the National Academy of Sciences

2022

63

Corosolic acid impairs tumor development and lung metastasis by inhibiting the immunosuppressive activity of myeloid‐derived suppressor cells

Hasita Horlad, Yukio Fujiwara, Kenichi Takemura,

Molecular Nutrition & Food Research

2013

62

Page 1